Characterisation of Collagen Re-Modelling in Localised Prostate Cancer Using Second-Generation Harmonic Imaging and Transrectal Ultrasound Shear Wave Elastography by Ageeli, Wael et al.
                                                                    
University of Dundee
Characterisation of Collagen Re-Modelling in Localised Prostate Cancer Using Second-
Generation Harmonic Imaging and Transrectal Ultrasound Shear Wave Elastography











Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Ageeli, W., Zhang, X., Ogbonnaya, C. N., Ling, Y., Wilson, J., Li, C., & Nabi, G. (2021). Characterisation of
Collagen Re-Modelling in Localised Prostate Cancer Using Second-Generation Harmonic Imaging and
Transrectal Ultrasound Shear Wave Elastography. Cancers, 13(21), [5553].
https://doi.org/10.3390/cancers13215553
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 08. Dec. 2021
cancers
Article
Characterisation of Collagen Re-Modelling in Localised
Prostate Cancer Using Second-Generation Harmonic Imaging
and Transrectal Ultrasound Shear Wave Elastography
Wael Ageeli 1,2, Xinyu Zhang 3, Chidozie N. Ogbonnaya 1, Yuting Ling 4, Jennifer Wilson 5, Chunhui Li 6
and Ghulam Nabi 1,*


Citation: Ageeli, W.; Zhang, X.;
Ogbonnaya, C.N.; Ling, Y.; Wilson, J.;
Li, C.; Nabi, G. Characterisation of
Collagen Re-Modelling in Localised
Prostate Cancer Using Second-
Generation Harmonic Imaging and
Transrectal Ultrasound Shear Wave
Elastography. Cancers 2021, 13, 5553.
https://doi.org/10.3390/
cancers13215553
Academic Editors: David D. Roberts
and Claudio Luparello
Received: 16 September 2021
Accepted: 3 November 2021
Published: 5 November 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Division of Imaging Sciences and Technology, School of Medicine, University of Dundee, Ninewells Hospital,
Dundee DD1 9SY, UK; w.ageeli@dundee.ac.uk (W.A.); c.z.ogbonnaya@dundee.ac.uk (C.N.O.)
2 Diagnostic Radiology Department, College of Applied Medical Sciences, Jazan University, Al Maarefah Rd,
P.O. Box 114, Jazan 45142, Saudi Arabia
3 Division of Population Health and Genomics, School of Medicine, University of Dundee,
Dundee DD1 9SY, UK; 110023382xyz@gmail.com
4 Imaging Science and Technology, School of Medicine, University of Dundee, Dundee DD1 9SY, UK;
y.x.ling@dundee.ac.uk
5 Department of Pathology, Ninewells Hospital, Dundee DD1 9SY, UK; jennifer.wilson7@nhs.scot
6 School of Science and Engineering, University of Dundee, Dundee DD1 4HN, UK; c.li@dundee.ac.uk
* Correspondence: g.nabi@dundee.ac.uk
Simple Summary: The study investigated the prostate cancer microenvironment and the correlation
between peritumoral collagen and aggressivity of cancer. We used novel and advanced imaging
including next-generation sequencing to characterise the expression of collagen in the extracellular
matrix. Type and contents of collagen varied according to the Gleason grade in prostate cancer in
men with localised prostate cancer undergoing radical surgery. The collagen contents orientation
seen on second harmonic generation imaging varied with the grade of cancer and can predict
clinically significant prostate cancer. Increased expression of Col1A1 is present in cancer tissues and
associated with increased tissue modulus as measured by ultrasound shear wave elastography in
prostate cancer. The study adds knowledge to our understanding of prostate cancer and defines the
microenvironment of clinically significant prostate cancer, a disease more likely to impact survival
and outcome of men who suffer from it.
Abstract: Prostate cancer has a poor prognosis and high mortality rate due to metastases. Extracel-
lular matrix (ECM) re-modelling and stroma composition have been linked to cancer progression,
including key components of cell migration, tumour metastasis, and tissue modulus. Moreover, col-
lagens are one of the most significant components of the extracellular matrix and have been ascribed
to many aspects of neoplastic transformation. This study characterises collagen re-modelling around
localised prostate cancer using the second harmonic generation of collagen (SHG), genotyping and
ultrasound shear wave elastography (USWE) measured modulus in men with clinically localised
prostate cancer. Tempo-sequence assay for gene expression of COL1A1 and COL3A1 was used to
confirm the expression of collagen. Second-harmonic generation imaging and genotyping of ECM
around prostate cancer showed changes in content, orientation, and type of collagen according to
Gleason grades (cancer aggressivity), and this correlated with the tissue modulus measured by USWE
in kilopascals. Furthermore, there were clear differences between collagen orientation and type
around normal and cancer tissues.
Keywords: prostate; collagen; second-generation harmonics; shear wave; elastography; ultrasound
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1. Introduction
Prostate cancer is a public health issue with a significant impact on society because
of its high incidence rate, and it is the second leading cause of cancer death in men
around the world [1]. Prostate cancer development and progression to metastases is now
widely recognised as a phenomenon of complex interactions between the cells of the
prostate epithelial compartment and the surrounding stromal compartment in which they
survive [2]. Cancer development normally starts with cells acquiring mutations that enable
them to proliferate uncontrollably and overcome intrinsic mechanisms that regulate tissue
homeostasis. Cells evolve over time to include the tumour microenvironment, consisting
of various stromal cells, immune cells, and the extracellular matrix (ECM) in which all cells
are embedded [3–5]. Several studies have reported that the biophysical and biochemical
properties of the tumour microenvironment differ from those in normal tissues [6–8].
Several characteristics of the tumour microenvironment have been identified, includ-
ing acidosis, high interstitial fluid pressure, hypoxia, and increased ECM modulus [2].
Liu et al. [9] summarised dynamic changes in the ECM due to cancer-associated fibrob-
lasts (CAFs) as “desmoplasia” and suggested that these alterations were related to cancer
metastases. Measurement of tissue modulus could potentially provide insights into the
characteristics of the tumour microenvironment. According to Zhou et al. [9], the “stiff
rim” sign was a unique characteristic of breast lesions on ultrasound shear wave elastog-
raphy (SWE) imaging. However, the cause of biological characteristics of tissue modulus
in prostate cancer is not well understood. CAFs secrete a high level of ECM proteins,
including type I and type II collagen, fibronectin (Fn), and express oncofetal isoforms of
Fn [8,10–13]. The alteration of matrix modulus is an immediate result of contractility-driven
ECM re-modelling. Bundling collagen filaments and crosslinking collagen networks by
CAFs cause additional modulus in the ECM [14,15]. Furthermore, collagen regulation is a
crucial histopathological characteristic that distinguishes reactive stroma from the normal
stroma and is linked to prostate cancer progression [16–19].
The elastic modulus of prostate cancer tissue is higher than that of normal prostate
glandular tissue [19], and changes in elasticity can indicate an abnormal pathologic mecha-
nism as tissue elasticity is a result of increased cell density and collagen formation [16,17].
Recently, there has been a surge of interest in measuring the elastic properties of prostate
cancer [18,20–22].
Ultrasound shear wave elastography (USWE) is a promising imaging technique that
measures tissue modulus and is increasingly applied for cancer detection [23]. Previ-
ous studies reported that USWE can distinguish malignant from benign in prostate can-
cer [24,25]. Previous studies have also reported that USWE based on its tissue modulus
measurement has varying sensitivity, specificity, positive predictive value, and negative
predictive value in the detection of prostate cancer [21,25,26], and these results may be
linked to pathological features of cancer lesions such as fibrosis, hyperplasia, prostatitis,
and ECM. What contributes to the increased modulus of cancers measured by USWE
remains unknown and poorly understood. Furtherance of knowledge, particularly image
characterisation of epithelial-stromal microenvironmental features would be a significant
advantage in understanding the behaviour of prostate cancer, including its response to
therapy. Collagen forms a major component of the tumour microenvironment and influ-
ences tumour behaviours through signalling pathways [27]. Changes in collagen content
in the extracellular matrix have been ascribed to the mutual feedback loop that influences
prognosis, recurrence, and resistance in cancers.
Imaging and quantification of collagen deposition around cancer would be a signifi-
cant advantage in understanding cancer and its progression. Second-harmonic generation
of collagen (SHG) microscopy is a common imaging technique for visualising and char-
acterising noncentrosymmetric 3D structures such as collagen [28]. We have previously
reported its application in prostate cancer biopsy tissues [29]. In this study, we aim to:
Characterise collagen orientation and distribution around prostate cancer in compari-
son to normal tissue using SHG and correlate this with the Gleason grade of prostate cancer.
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2. Materials and Methods
2.1. Study Design and Patients
This was a prospective, protocol-driven study with ethical approval obtained through
the East of Scotland Ethical committee and Caldicott permission (IGTCAL5626) to access
healthcare follow-up data [30]. Tissue request approval was granted from the Tayside
tissue bank, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Inclusion criteria were: confirmed prostate cancer on TRUS guided biopsies, coupled
with USWE imaging, and confirmed by radical prostatectomy. Patients were excluded by
the following: previous radiotherapy or resection/intervention or hormonal treatment,
including the use of 5 alpha-reductase inhibitors.
Thirty men undergoing radical prostatectomy with three risk categories were recruited
in this study: low-risk GS (GS = 6) prostate cancer (n = 10); intermediate-risk GS (GS 3 + 4)
prostate cancer (n = 10); and high-risk GS (GS 8 or more) prostate cancer (n = 10). Patient-
specific customised 3D moulds were printed using imaging and 3D printed according to
our published protocol [31].
2.2. Ultrasound Shear Wave Elastography
All men had ultrasound shear wave elastography (USWE) before surgery. The USWE
technique measures the shear wave speed produced using a specialised ultrasound trans-
ducer SE 12-3 that generates and measures shear wave speed A dynamic map of the tissue
modulus (described as a Young Modulus) is reflected as a different speed in each tissue
area in real-time [32,33]. All USWE images were taken with patients in either a lateral or
lithotomy position utilising a transrectal endocavitary transducer (SuperSonic Imagine,
Aix en Provence, France). For each prostate lobe, the USWE mode was used to capture
elastograms of the prostate from the cranial to the caudal direction. In transverse planes
with a spacing of 4 to 6 mm, the USWE pictures were obtained from base to apex. The most
likely cancer-carrying planes were identified, and 3D pictures were created offline. When
scanning suspected cancer areas with the transducer rotated in different directions, the
anomalies were verified, and the dimensions were measured accurately. USWE examina-
tions were performed by an experienced urologist with more than 10 years of experience in
transrectal ultrasound.
2.3. Second-Harmonic Generation (SHG) Imaging
The histopathology of each cancer lesion (from the histopathology slides) was marked
and graded by an experienced uro-pathologist (JW). The tissues of the 30 patients were
scanned by SHG to investigate collage distribution and orientation in different grades of
prostate cancer along with genotyping for collagen. The ROI was 0.5 cm in width and 2 cm
in length. SHG imaging was carried out on an upright Leica SP8 multi-photon microscope
system at Dundee Imaging Facility. An HC Plan Fluotar 10 × 0.3 NA objective lens was
used for all imaging. The second harmonic signal was generated using 880 nm from a
Spectra-Physics InSight laser, and a transmitted light image was generated using a 488 nm
laser. Both the SHG and transmitted light images were collected onto separate PMTs in the
forward (transmitted) position using frame sequential acquisition. The SHG signal was
collected with a 440/20 nm bandpass filter and the transmitted light image was collected
through a 483/32 nm bandpass filter. The Navigator function of the Leica LAS X software
was used to define the region of the section for imaging and set focus points across that
region. The frame size was set to 1024 × 1024 pixels, giving 1.082-micron pixels and a
bit depth of 12. A bi-directional scan at 400 Hz was used for all acquisitions. Any phase
inaccuracies of the bi-directional scan were corrected post-acquisition.
Collagen fibre alignment in each section was measured using Fourier transform sec-
ond harmonic generation (FT-SHG), as mentioned in a previous study [29]. The processing
algorithms were developed in MATLAB R2017a (The MathWorks, Natick, MA, USA) to
quantify the alignment of collagen fibres in each section utilising Fourier transform second
harmonic generation adapted from the previously reported studies [34–41]. This technique
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was used to identify the quantitative parameters representing collagen orientation and
distribution in the radical prostatectomy of prostate cancer by assessing the spatial fre-
quencies within an image using a 2D-FT. Fast Fourier transformations were used to make
the 2D-FT images. It was then radially integrated over various angles, yielding a plot
of amplitude as a function of orientation angle. The plot was then fitted with Gaussian
fits. The orientation of fibres was depicted in the centre of the fit, and the width of the
fit was a measurement of the randomness with which the fibres were distributed. The
angular power spectrum is used to determine whether a region is isotropic or anisotropic.
According to the experimental results and the literature [38], a single sharp peak in the an-
gular power spectrum refers to a region containing fibres all oriented in the same direction,
whereas multiple peaks in the power spectrum correspond to several various directions
that fibres are oriented along. As a result, the A:I ratio measures the number of areas with
strongly aligned fibres in contrast to those with randomly oriented fibres. The preferred
orientation in each plane was defined as the direction along which the majority of fibres
appeared to align. The high amplitudes in 2D-FT were on average aligned perpendicularly
to the preferred orientation. The original image was divided into 100 sub-images with a
size of 50 µm and classified into three groups: negligible, anisotropic, or isotropic. This
was performed to rapidly calculate the preferred orientation. If the SHG signal intensity
in the region was low or almost dark, it was considered negligible. The sub-images with
preferential collagen fibre orientation were labelled anisotropic, while those with several
different directions were labelled isotropic. The A:I ratio was used to determine the overall
orientation of the collagen fibres in each region (the ratio of the number of anisotropic to
isotropic sub-images).
2.4. Radical Prostatectomy Histopathology as Reference Standard
According to our published protocol, a unique customised 3D mould was designed
for each patient in this study using imaging data and a 3D printer [31]. The moulds were
printed prior to surgery based on the T2-weighted mpMRI prostate images. They were
designed to keep prostates after surgical removal in the same form and orientation as
seen on the MRI. The 3D mould has a series of evenly spaced parallel slits, each of which
corresponds to a recognised slice of T2-weighted MRI. This allows pathologists to gross
specimens in the same orientation as imaging.
2.5. Genomic Analysis of mRNA Expression
We used TempO-Seq assays (BioSpyder., Inc. BIOCLAVIS, LTD, Biotechnology com-
pany in Glasgow, Scotland), a highly efficient multiplexed molecular profiling technique to
target sequencing-based RNA expression analysis on FFPE tissue sections of the human
prostate. Our samples were fixed in a slide with two regions of interest mapped out from
each sample (normal prostate tissue and cancerous tissue) before excision of 10 mm was
taken for both regions. The samples were analysed using the BioClavis’ internal process
controls and with the Human Whole Transcriptome v2.0 panel with standard attenuators.
In TempO-Seq, each Detector Oligo contains a sequence complementary to an mRNA target
and a universal for all of the targeted gene primer binding sites. They anneal directly in
juxtaposition to each other on the targeted RNA template in a way they can be ligated
together. Subsequently, the Ligated detector oligos were PCR-amplified using a primer
set (single-plex PCR reaction, with a single primer pair for each of the samples), which
introduced both the adaptors needed for sequencing and a sample-specific barcode. Then
the barcode sequences flanked by the target sequence were properly introduced into the
standard Illumina adaptors to permit standard dual-index sequencing of the barcodes and
deconvolution of sample-specific reads from the sequencing data using a standard Illumina
software. All the amplified and PCR and barcoded samples were linked into a single
library for sequencing and the sequencing reads were de-multiplexed using a standard
sequencing instrument software for each sample. Subsequently, we used the barcodes to
create individual FASTQ files. A data matrix of gene expression level with sample names
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as column headers and gene names as rows was used to identify COL1A1 and COL3A1
used for further analysis.
2.6. Data Analysis
The following data were collected: Patient’s age (in years); prostate-specific antigen
(PSA); prostate volume (in mL); prostate-specific antigen density (PSAD); modulus mea-
surement using USWE (in kpa); Gleason Score (GS); and orientation of collagen fibres (A:I
ratio) in the prostate cancer and benign areas. PSAD was calculated using PSA divided
by the prostate volume. Continuous data were first tested to see if they were normally
distributed by the Kolmogorov–Smirnov Test of Normality. The mean (m) and standard
deviation (SD) were described if the variable followed a normal distribution. The median
(M) and interquartile range (IQR) were presented if the variable did not follow a normal
distribution. Independent-sample t-tests were used to compare the means of the contin-
uous variables that were normally distributed. Categorical variables were reported as
frequencies and proportions. In this study, a GS ≥ 4 + 3 was considered to be significant
prostate cancer following the UCL 2 definition. Collagen orientation (A:I ratio) in normal
and cancer prostate tissue were compared. Cancer tissue collagen orientation (A:I ratio)
against different GS were compared as well. The relationship between prostate cancer
tissue modulus and collagen orientation was examined by Pearson Correlation. The rela-
tionship between prostate cancer tissue collagen orientation and GS was examined by the
Spearman rank correlation. Statistical analyses were conducted using SPSS V23.0. A gene
expression analysis for identifying the collagen types was conducted to validate the results
from SHG.
Data are available on request from the authors.
3. Results
A Spearman rank correlation was conducted to examine the relationship between the
prostate cancer Gleason score and USWE modulus. The mean for collagen orientation in
each Gleason score category was 100.7 ± 4.2, 116.7 ± 14.1, 128.5 ± 6.5, 144.2 ± 21.6 and
149.1 ± 22.5 (Figure 1). The relationship was positive, medium in strength and statistically
significant (rs = 0.67, p < 0.001, df = 28).
Figure 1. Bar chart of the Gleason score and USWE modulus in 30 patients with prostate cancer (the
bar is the mean modulus in each Gleason score category with standard deviation sitting on the top of
the bar), (rs = 0.67, p < 0.001, n = 30).
Figure 2 shows that the normal prostate tissue is composed of the gland and sur-
rounding stroma. On the one hand, in Figure 2a, the typical gland is composed of two
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layers of cells (the inner layer is epithelia and the outer layer is basal cells) and has a
papillary projection view. On the other hand, Figure 2d shows cancer prostate tissue that
has lost the basement membrane and shows a disrupted epithelial layer compared to
normal prostate tissue.
Figure 2. Comparison between normal prostate tissue and cancer prostate tissue. SHG images of
collagen alignment in (a) normal prostate tissue and (b) cancer prostate tissue. Histopathology
images of (c) normal prostate glands and (d) fused prostate glands occupied by cancer cells. The
scale bar is 100 µm. The microscope magnification is 200×.
Furthermore, the shape of the gland in cancer tissue has changed from papillary to
reticular. As expected, the SHG detected changes in the fibromuscular stroma containing
the collagen. Compact, loose, crosslink, and more oriented collagen were observed in
the prostate cancer tissue compared to normal prostate tissue. Increased GS of prostate
cancer leads to increased collagen orientation and crosslinking, which may cause increasing
prostate cancer tissue modulus. Figure 3 shows different grades of cancers and collagen
orientation around cancer foci.
The pattern of the SHG signal in the images can be distinguished between different
GS, as seen in Figure 3. The A:I ratio was used to calculate the regularity of collagen
fibre orientation and to compare GS across radical prostatectomies. In general, prostate
cancer tissues collagens were found to be more aligned than prostate normal tissues. When
comparing the collagen orientation in cancer and normal prostate tissue, after testing for
normality, there was a significant difference in cancer A:I ratio (m = 3.21, SD = 1.09) and
normal A:I ratio (m = 2.09, SD = 0.45); the F-test for the significance of the difference between
the variances of the two samples was statistically significant (F = 5.94, p < 0.001), suggesting
to use the t-test result assuming unequal sample variances; t(38.5) = 5.19, p < 0.001. These
results suggest that collagen orientation in cancer prostate tissue is statistically higher than
that in normal prostate tissue, as presented in Table 1.
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Figure 3. Prostate cancer sections with different Gleason scores. (A1–A5) SHG images, and (B1–B5)
H&E images. In specimens with prostate cancer GS 3 + 3 (1), the SHG signals in prostate cancer were
surrounding the glands with more closed margins; however, these became fainter and partially lost
in GS 3 + 4 (2) and 4 + 3 (3). As the cancer is more aggressive GS (3 + 5 (4) and 4 + 5 (5)), the cancer
cells fill the gland, and some spread to the stroma. In GS 4 + 5, the glands are fused, and there are
only sheets of cancer cells left with no glandular shape. The scale bar is 300 µm, and the microscope
magnification is 100×.
Table 1. Comparison of collagen orientation (A:I ratio) between normal and cancerous prostate
tissue.
Tissue n df * t-Value p Mean ∆mean 95% CI of
∆mean
Cancer Tissue 30 38.5 5.19 <0.001 3.21 1.12 0.68 to 1.56
Normal Tissue 30 2.09
* df, degrees of freedom; ∆mean, the difference between the means in each group; F-test found unequal sample
variances.
Furthermore, the A:I ratio increased with a higher GS, indicating that the collagen
fibre became more oriented as the prostate cancer became more aggressive, as shown in
Table 2 and Figure 4.
Table 2. The comparison of cancer orientation among prostate cancer and Gleason Grade.
Gleason Grade Number of Patients(n = 30)
Cancer Orientation





3 + 3 3 1.6 ± 0.28 1.31 1.79
3 + 4 14 2.5 ± 0.01 2.21 2.81
4 + 3 4 3.8 ± 0.1 3.62 4.12
3 + 5 3 4.4 ± 0.4 4.11 4.62
4 + 5 6 4.6 ± 0.25 4.31 4.92
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Figure 4. Violin Plot showing data distribution between cancer fibre orientation and Gleason score
groups (grey rectangular sport in each violin is the mean of each group).
When comparing collagen orientation in cancer and normal prostate tissue, after test-
ing for normality, there was a significant difference in cancer A:I ratio in significant cancer
(m = 4.57, SD = 0.26) and insignificant cancer (m = 2.62, SD = 0.72); F-test for the significance
of the difference between the variances of the two samples was statistically significant
(F = 7.91, p = 0.003), suggesting using the t-test result assuming unequal sample variances;
t (27.72) = 10.87, p < 0.001. The results suggest that the cancer tissue collage orientation in
significant prostate cancer patients is statistically higher than that in insignificant prostate
cancer patients, as presented in Table 3.
Table 3. Comparison of cancer collagen orientation (A:I ratio) between clinically significant and
insignificant prostate cancer.
Prostate




Cancer 9 27.72 10.87 <0.001 4.57 1.95 1.58 to 2.32
Insignificant
Cancer 21 2.62
* df, degrees of freedom; ∆mean, the difference between the means in each group; F-test found unequal sample
variances; Gleason score ≥ 4 + 3 was considered to be significant prostate cancer.
A Pearson correlation examined the relationship between prostate cancer modulus
and tissue collagen orientation. The mean for modulus was 125.9 (SD = 21.6), and the mean
for collagen orientation was 3.2 (SD = 1.1). The relationship was positive, strong in strength
and statistically significant (r(28) = 0.74, p < 0.001), as seen in Figure 5.
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Figure 5. Scatter plot of the USWE modulus and SHG collagen orientation in 30 patients with prostate
cancer (r = 0.74, p < 0.001, n = 30).
In order to measure how well the line fits the data, residuals were calculated and
plotted against the explanatory variable, which is the A:I ratio (Figure 6). The plot showed
no systematic curvature nor major outliers, which indicated it was a reasonable residual
plot and therefore the line fits the data well.
Figure 6. Residual plot between residuals and cancer orientation.
A Spearman rank correlation was conducted to examine the relationship between
prostate cancer GS and tissue collagen orientation. The mean for collagen orientation
in each GS category was 1.6 ± 0.3, 2.5 ± 0.01, 3.8 ± 0.1, 4.4 ± 0.4, and 4.6 ± 0.1. The
relationship was positive, very strong in strength and statistically significant (Spearman
rank correlation coefficient rs = 0.93, p < 0.001, df = 28), as shown in Figure 7.
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Figure 7. Bar chart of Gleason score and cancer collagen orientation in 30 patients with prostate
cancer (the bar is the mean A:I ratio in each Gleason score category with standard deviation sitting
on the top of the bar), rs = 0.93, p < 0.001, n = 30.
The gene expression for COl1A1 in the cancer area was higher than Col3A1. The
means of the gene expression level of COL1A1 in prostate cancer tissue in GS 3 + 3, 3 + 4,
4 + 3, 3 + 5, and 4 + 5 were 383, 920.6, 2729, and 927, respectively, while in COL3A1 they
were 48.6, 114.2, 198.5, and 163.7, respectively. Col1A1 collagen demonstrates most of the
fibres in cancer tissue compared to Col3A1 collagen.
4. Discussion
In this study, we investigated the prostate cancer modulus using USWE and further
characterised this with SHG to detect the content and orientation of collagen. To validate
the results, we presented gene expression to identify the collagen types associated with
cancer modulus. Thirty patients with prostate cancer were recruited in this study. Using the
MATLAB code on R2017a (The MathWorks, Natick, MA, USA) to identify the orientation
of collagen in SHG images, the methodology appeared to offer a highly accurate and
promising way of differentiating cancer tissue from normal tissue in the prostate gland.
Moreover, it provided a precise characterisation of the GS based on the measurements
of tissue modulus and orientation of collagen in cancer lesions. The study provides a
mechanistic proof of tissue modulus by clearly showing type 1 collagen around cancer
tissue with a high degree of preferred orientation. This increases with the grade of cancer.
The dynamic behaviour of collagen around cancer provides tensile strength to tissue and
may be responsible for tissue modulus similar to the observation by Whelan A et al. [42].
In fact, the longevity of prosthetic heart valves and their failure depends on the collagen
orientation of the original structure [43], indirectly indicating that it is not the content of
collagen but the orientation that contributes to the tensile strength of the tissues.
To address the limitations of existing prostate cancer detection techniques, a compre-
hensive strategy is required. The ability of USWE to significantly improve prostate cancer
detection has been demonstrated. USWE identifies and locates tumours by detecting spe-
cific differences in tissue elasticity [44]. In the detection of prostate cancer, USWE has shown
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high sensitivity, specificity, and accuracy [20,22,25,26,45,46]. USWE provides elastograms
that offer additional detail and clarity based on the measurement of tissue modulus. The
range of tissue modulus could predict a higher GS cancer with the final histopathological
examination of a radical prostatectomy specimen. In this study, we further characterised
the modulus using the SHG optically nonlinear coherent process where the emitted light
has exactly half the wavelength of the two-incident photon [47]. The technique specifi-
cally measures collagen fibres due to their crystalline and noncentrosymmetric properties.
There were clear distinctions between cancer and normal lesions in the structural images
of the prostate tissue of the radical prostatectomy in SHG images. Our observations are
similar to other colleagues reporting tumour tissues had few and straight collagen fibres
that displayed higher anisotropy values than normal skin and breast tissue [48]. When
comparing breast cancer tissue to normal tissue, changes in collagen alignment have been
observed in the stroma [49,50]. Raghu et al. reported that the ratio of collagen orientation in
breast biopsy tissue was 2.8 ± 1.5 for normal samples and 11.6 ± 6.7 for cancer tissues [38].
Yuting et al. reported that the ratio of collagen orientation in prostate biopsy tissue was
1.34 ± 0.19 for normal samples and 2.82 ± 0.62 for cancer tissues [29]. However, in this
study, the radical prostatectomies histopathology of a larger patient cohort included a
bigger and more accurate area of tissue scanned using SHG signal obtained in the forward
direction. Subsequently, the collagen pattern was then generated for each lesion, and the
resultant collagen orientation was computed by FFT-SHG. A papillary collagen pattern
was found in normal tissue, while a reticular and sparse collagen pattern was found in the
cancer tissue. In normal prostate tissue, isotropic collagen fibres were observed without a
preferred orientation. However, collagen orientation changed in prostate cancer tissue, and
this became more obvious as the prostate cancer became more aggressive. In normal tissue,
collagen fibres were oriented in different directions, whereas in cancers, a higher orientation
(anisotropy) was observed. In this study, we investigated the relationship between the
orientation of collagen and GS, as well as the relationship between collagen orientation
and tissue modulus. The collagen orientation information addressed the increase in tissue
modulus in the prostate cancer tissue compared to normal, benign prostate tissue. From
the gene expression results, we observed that the amount of COL1A1 increased in cancer
tissue compared to COL3A1. Tord et al. reported that COL1A1 collagen demonstrates most
of the fibres in cancer tissue, which is similar to our results [48]. Liu et al. recently reported
the potential role of COL1A1 in the development of metastases and suggested that this
could be a target for future drug development in breast cancer [51].
5. Conclusions
The study using novel imaging provides mechanistic proof of tissue modulus, includ-
ing orientation, dispersion and type of collagen around normal and prostate cancer tissues.
There is a correlation between the type of collagen and the content of collagen, including
orientation and prostate cancer aggressivity. Differences in collagen content, orientation,
distribution, structures, and type play a critical role in prostate cancer modulus and thus
act as a critical marker for distinguishing the different GS of prostate cancer from normal
tissue.
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